jonas schreef:
In het kader van het onderzoek: nu Galapos. Oogt wel interessant. Allianz en Kempen zitten erin.
Werknemers 454, wel E 35 mln goodwill op de balns (Biofocus). Omzet E 11,2 en ter geruststelling van veel Pharmingforumgangers: ook nog een stevig verlies van E 11,2 mln in 2006!
"On 31 December 2006, the Executive Committee comprised eight members, Mr Van de Stolpe, Dr Pollet,
Dr Dixon, Mr Hoekema, Dr Newton, Mr Phillips, Mr Smith and Mr Neale. Their combined remuneration
package comprises:
Thousands of € (except for the Number of warrants) 2006 2005 2004
Short-term employee benefits 2,097 1,271 574
Post-employment benefits 296 78 46
Total benefits excluding warrants 2,393 1,349 620
Number of warrants offered in the year 80,000 361,250
The Executive directors provide their services full time for the Group. Their remuneration includes all
costs for the Group, including retirement contributions made by the executive directors. The warrants
offered to the executive directors are under the same conditions as set out in note 28. These warrants
are granted under the Belgian 2005, 2002 and 1999 plans.
The retirement benefits to the Executive Committee, excluding the executive directors, are part of the
retirement benefit scheme to which all qualified personnel are entitled. The contributions are paid as a
percentage of the gross annual salary.
Certain employees, including the Executive Committee, are part of a Group bonus scheme established in
2006 where half of the bonus is paid immediately post year end and half is deferred for three years. The
deferred component is only payable in full provided that the growth in the company share price has
exceeded the growth in the FTSE Actuaries Share Index of Pharmaceutical and Biotechnology over the
same three year period. Where the Company share price underperforms against the index, then the
payout is reduced, with no payment made if the Company underperforms by more than 10%. The
Company has taken a charge to G&A of €200,000 to cover this contingent liability.
In 2006, the members of the Executive Committee (including the CEO) were paid an aggregate amount of
€1,739,993 in salaries and an aggregate amount of €683,000 in bonuses. Other components of their
remuneration include contributions to the Company’s pension and health insurance schemes, and certain
fringe benefits of non-material value.
50.
Groet, Jonas